• PA
    PA School SurvivalDidactic Year
Study
  • Dashboard
  • Medical Terminology
  • Flashcards
  • Progress
  • Prep Rounds
  • Body Systems
  • Pharmacology
  • Tools
  • Guide & FAQ
  • Suggest a FeatureLet us know what we can do better — we genuinely want to help you in class.
My material
  • My Library
  • Notes & Sketches
PANCE Body Systems
  • Cardiovascular
    11%
  • Pulmonary
    9%
  • Gastrointestinal/Nutrition
    8%
  • Musculoskeletal
    8%
  • Neurology
    7%
  • Infectious Disease
    7%
  • Psychiatry/Behavioral
    7%
  • Reproductive
    7%
  • Endocrine
    6%
  • Eyes/Ears/Nose/Throat
    6%
  • Hematology
    5%
  • Renal
    5%
  • Genitourinary
    4%
  • Dermatology
    4%
Weights are study aids — verify each exam cycle.
⌘K
NotesPricingSign in
About·Tools·Terminology·Privacy Policy·Terms of Service·PANCE Blueprint

PANCE® is a registered trademark of the National Commission on Certification of Physician Assistants (NCCPA). This application is an independent study resource and is not affiliated with, sponsored by, or endorsed by the NCCPA.

For educational use only. Content is AI-generated, may contain errors, and is not medical advice — always verify against current primary sources and faculty guidance before clinical use.

HomePharmacologyFlumazenil

Flumazenil

Benzodiazepine Antagonist
Drug Class
Benzodiazepine Antagonist
Mechanism of Action (MOA)
Competitively blocks the benzodiazepine site on the GABA-A receptor → reverses benzodiazepine sedation.
Black Box Warning
Risk of seizures — can precipitate life-threatening benzodiazepine withdrawal seizures, especially in dependent patients or mixed (e.g., TCA) overdose.
Clinical Notes
Reversal of benzodiazepine sedation (e.g., procedural). Avoid in chronic benzodiazepine users and suspected TCA co-ingestion; short half-life → resedation may occur.
Source
FDA label (DailyMed)
All pharmacology